Latest Updates

Stroke and Other Cerebrovascular Diseases

Scott E. Kasner, MD, MSCE, FAHA, FAAN, Christina A Wilson, MD, PhD
    • Recent advances in endovascular therapy for acute ischemic stroke
    • Updated guidelines for administration of intravenous recombinant tissue plasminogen activator
    • Recent advances in antithrombotic choice for directed secondary stroke prevention
    • Current recommendations for the management of acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage

Understanding Patient Safety in Surgical Care

Amir Ghaferi, MD, MS, FACS
    • The widespread adoption of a systems-based approach to surgical patient safety across healthcare systems
    • Public reporting and ongoing critical evaluation of surgical quality measures with an emphasis on ensuring surgeons are more aware of these measures and their implications
    • Increased emphasis on the education of future surgeons and healthcare leaders on quality measurement and evaluation has resulted in significant gains in the understanding of surgical safety

Understanding Patient Safety in Surgical Care

Amir Ghaferi, MD, MS, FACS
    • The widespread adoption of a systems-based approach to surgical patient safety across healthcare systems
    • Public reporting and ongoing critical evaluation of surgical quality measures with an emphasis on ensuring surgeons are more aware of these measures and their implications
    • Increased emphasis on the education of future surgeons and healthcare leaders on quality measurement and evaluation has resulted in significant gains in the understanding of surgical safety

Neurologic Diseases in Pregnancy 

Emily L Johnson, MD, Peter W Kaplan, MBBS
    • Lamotrigine and levetiracetam are preferred in pregnancy, while valproate should be avoided.
    • Tissue plasminogen activator (tPA) should be considered in pregnant women with potentially disabling strokes.
    • Noncontrast magnetic resonance imaging is safe for use in pregnancy.

Understanding Patient Safety in Surgical Care

Amir Ghaferi, MD, MS, FACS
    • The widespread adoption of a systems-based approach to surgical patient safety across healthcare systems
    • Public reporting and ongoing critical evaluation of surgical quality measures with an emphasis on ensuring surgeons are more aware of these measures and their implications
    • Increased emphasis on the education of future surgeons and healthcare leaders on quality measurement and evaluation has resulted in significant gains in the understanding of surgical safety

Epidemiology of Male Infertility 

Omer A Raheem, MD, Thomas J Walsh, MD
    • Male infertility is not a reportable disease.
    • Frequently, the empiric treatment of male factor infertility involves assisted reproductive technology (in vitro fertilization) that primarily treats the female partner.
    • Male infertility is variable with a multitude of influencing factors (racial variation, geographical variation, at-risk groups, and associated conditions including medical and environmental factors) that are of the utmost importance to a larger audience of clinicians from varying specialties.

Epidemiology of Male Infertility 

Omer A Raheem, MD, Thomas J Walsh, MD
    • Male infertility is not a reportable disease.
    • Frequently, the empiric treatment of male factor infertility involves assisted reproductive technology (in vitro fertilization) that primarily treats the female partner.
    • Male infertility is variable with a multitude of influencing factors (racial variation, geographical variation, at-risk groups, and associated conditions including medical and environmental factors) that are of the utmost importance to a larger audience of clinicians from varying specialties.

Genomic Landscape of Prostate Cancer and Opportunities for Precision Oncology

Himisha Beltran, MD, Sheng-Yu Ku, PhD, Panagiotis J Vlachostergios , MD, PhD
    • Updates on the genomic landscape of prostate cancer with a focus on clinical implications
    • Emerging resistance mechanisms and targetable molecular alterations in metastatic castration-resistant prostate cancer
    • Discussion of ongoing molecularly-driven clinical trials for patients with metastatic castration-resistant prostate cancer
    • Future directions for precision oncology for patients with advanced prostate cancer
« Previous | Next »
Updates per yearSpecialty updatesNumber of sections